A survey on automated detection and classification of acute leukemia and WBCs in microscopic blood cells

Leukemia (blood cancer) is an unusual spread of White Blood Cells or Leukocytes (WBCs) in the bone marrow and blood. Pathologists can diagnose leukemia by looking at a person's blood sample under a microscope. They identify and categorize leukemia by counting various blood cells and morphological features. This technique is time-consuming for the prediction of leukemia. The pathologist's professional skills and experiences may be affecting this procedure, too. In computer vision, traditional machine learning and deep learning techniques are practical roadmaps that increase the accuracy and speed in diagnosing and classifying medical images such as microscopic blood cells. This paper provides a comprehensive analysis of the detection and classification of acute leukemia and WBCs in the microscopic blood cells. First, we have divided the previous works into six categories based on the output of the models. Then, we describe various steps of detection and classification of acute leukemia and WBCs, including Data Augmentation, Preprocessing, Segmentation, Feature Extraction, Feature Selection (Reduction), Classification, and focus on classification step in the methods. Finally, we divide automated detection and classification of acute leukemia and WBCs into three categories, including traditional, Deep Neural Network (DNN), and mixture (traditional and DNN) methods based on the type of classifier in the classification step and analyze them. The results of this study show that in the diagnosis and classification of acute leukemia and WBCs, the Support Vector Machine (SVM) classifier in traditional machine learning models and Convolutional Neural Network (CNN) classifier in deep learning models have widely employed. The performance metrics of the models that use these classifiers compared to the others model are higher

An Intelligent Decision Support System for Leukaemia Diagnosis using Microscopic Blood Images

This research proposes an intelligent decision support system for acute lymphoblastic leukaemia diagnosis from microscopic blood images. A novel clustering algorithm with stimulating discriminant measures (SDM) of both within- and between-cluster scatter variances is proposed to produce robust segmentation of nucleus and cytoplasm of lymphocytes/lymphoblasts. Specifically, the proposed between-cluster evaluation is formulated based on the trade-off of several between-cluster measures of well-known feature extraction methods. The SDM measures are used in conjuction with Genetic Algorithm for clustering nucleus, cytoplasm, and background regions. Subsequently, a total of eighty features consisting of shape, texture, and colour information of the nucleus and cytoplasm subimages are extracted. A number of classifiers (multi-layer perceptron, Support Vector Machine (SVM) and Dempster-Shafer ensemble) are employed for lymphocyte/lymphoblast classification. Evaluated with the ALL-IDB2 database, the proposed SDM-based clustering overcomes the shortcomings of Fuzzy C-means which focuses purely on within-cluster scatter variance. It also outperforms Linear Discriminant Analysis and Fuzzy Compactness and Separation for nucleus-cytoplasm separation. The overall system achieves superior recognition rates of 96.72% and 96.67% accuracies using bootstrapping and 10-fold cross validation with Dempster-Shafer and SVM, respectively. The results also compare favourably with those reported in the literature, indicating the usefulness of the proposed SDM-based clustering method

A Review on Classification of White Blood Cells Using Machine Learning Models

The machine learning (ML) and deep learning (DL) models contribute to exceptional medical image analysis improvement. The models enhance the prediction and improve the accuracy by prediction and classification. It helps the hematologist to diagnose the blood cancer and brain tumor based on calculations and facts. This review focuses on an in-depth analysis of modern techniques applied in the domain of medical image analysis of white blood cell classification. For this review, the methodologies are discussed that have used blood smear images, magnetic resonance imaging (MRI), X-rays, and similar medical imaging domains. The main impact of this review is to present a detailed analysis of machine learning techniques applied for the classification of white blood cells (WBCs). This analysis provides valuable insight, such as the most widely used techniques and best-performing white blood cell classification methods. It was found that in recent decades researchers have been using ML and DL for white blood cell classification, but there are still some challenges. 1) Availability of the dataset is the main challenge, and it could be resolved using data augmentation techniques. 2) Medical training of researchers is recommended to help them understand the structure of white blood cells and select appropriate classification models. 3) Advanced DL networks such as Generative Adversarial Networks, R-CNN, Fast R-CNN, and faster R-CNN can also be used in future techniques.Comment: 23 page

Novel Pipeline for Diagnosing Acute Lymphoblastic Leukemia Sensitive to Related Biomarkers

Acute Lymphoblastic Leukemia (ALL) is one of the most common types of childhood blood cancer. The quick start of the treatment process is critical to saving the patient's life, and for this reason, early diagnosis of this disease is essential. Examining the blood smear images of these patients is one of the methods used by expert doctors to diagnose this disease. Deep learning-based methods have numerous applications in medical fields, as they have significantly advanced in recent years. ALL diagnosis is not an exception in this field, and several machine learning-based methods for this problem have been proposed. In previous methods, high diagnostic accuracy was reported, but our work showed that this alone is not sufficient, as it can lead to models taking shortcuts and not making meaningful decisions. This issue arises due to the small size of medical training datasets. To address this, we constrained our model to follow a pipeline inspired by experts' work. We also demonstrated that, since a judgement based on only one image is insufficient, redefining the problem as a multiple-instance learning problem is necessary for achieving a practical result. Our model is the first to provide a solution to this problem in a multiple-instance learning setup. We introduced a novel pipeline for diagnosing ALL that approximates the process used by hematologists, is sensitive to disease biomarkers, and achieves an accuracy of 96.15%, an F1-score of 94.24%, a sensitivity of 97.56%, and a specificity of 90.91% on ALL IDB 1. Our method was further evaluated on an out-of-distribution dataset, which posed a challenging test and had acceptable performance. Notably, our model was trained on a relatively small dataset, highlighting the potential for our approach to be applied to other medical datasets with limited data availability

Quantitative-Morphological and Cytological Analyses in Leukemia

Leukemia, a blood cancer originating in the bone marrow, presents as a heterogeneous disease with highly variable survival rates. Leukemia is classified into major types based on the rate of cancerous cell growth and cell lineage: chronic or acute and myeloid or lymphoid leukemia. Histological and cytological analysis of the peripheral blood and the bone marrow can classify these major leukemia categories. However, histological analyses of patient biopsies and cytological microscopic assessment of blood and bone marrow smears are insufficient to diagnose leukemia subtypes and to direct therapy. Hence, more expensive and time-consuming diagnostic tools routinely complement histological-cytological analysis during a patient’s diagnosis. To extract more accurate and detailed information from patient tissue samples, digital pathology is emerging as a powerful tool to enhance biopsy- and smear-based decisions. Furthermore, digital pathology methods integrated with advances in machine learning enable new diagnostic features from leukemia patients’ histological and cytological slides and optimize patient classification, thus providing a cheaper, more robust, and faster diagnostic tool than current standards. This review summarizes emerging approaches to automatically diagnose leukemia from morphological and cytological-histological analyses

A Brief Bibliometric Survey of Leukemia Detection by Machine Learning and Deep Learning Approaches

Background: This study aims to analyze the work done on leukemia detection and diagnosis using machine learning, deep learning and different image processing techniques from 2011 to 2020, using the bibliometric methods. Methods: different articles on leukemia detection were retrieved using one of the most popular database- Scopus. The research articles are considered between 2011 to 2020. Scopus analyzer is used for getting some analysis results such as documents by year, source, county and so on. VOSviewer Version 1.6.15 is used for the analysis of different units such as co-authorship, co-occurrences, citation analysis etc. Results: In our study, a database search outputs a total of 617 articles on leukemia detection from 2011 to 2020. Statistical analysis and network analysis shows the maximum articles are published in the years 2019 and 2020 with India contributed the largest number of documents. Network analysis of different parameters shows a good potential of the topic in terms of research. Conclusions: Scopus keyword search outcome has 617 articles with English language having the largest number. Authors, documents, country, affiliation etc are statically analyzed and indicates the potential of the topic. Network analysis of different parameters indicates that, there is a lot of scope to contribute in the further research in terms of advanced algorithms of computer vision, deep learning and machine learning

Improved Otsu and Kapur approach for white blood cells segmentation based on LebTLBO optimization for the detection of Leukemia.

The diagnosis of leukemia involves the detection of the abnormal characteristics of blood cells by a trained pathologist. Currently, this is done manually by observing the morphological characteristics of white blood cells in the microscopic images. Though there are some equipment- based and chemical-based tests available, the use and adaptation of the automated computer vision-based system is still an issue. There are certain software frameworks available in the literature; however, they are still not being adopted commercially. So there is a need for an automated and software- based framework for the detection of leukemia. In software-based detection, segmentation is the first critical stage that outputs the region of interest for further accurate diagnosis. Therefore, this paper explores an efficient and hybrid segmentation that proposes a more efficient and effective system for leukemia diagnosis. A very popular publicly available database, the acute lymphoblastic leukemia image database (ALL-IDB), is used in this research. First, the images are pre-processed and segmentation is done using Multilevel thresholding with Otsu and Kapur methods. To further optimize the segmentation performance, the Learning enthusiasm-based teaching-learning-based optimization (LebTLBO) algorithm is employed. Different metrics are used for measuring the system performance. A comparative analysis of the proposed methodology is done with existing benchmarks methods. The proposed approach has proven to be better than earlier techniques with measuring parameters of PSNR and Similarity index. The result shows a significant improvement in the performance measures with optimizing threshold algorithms and the LebTLBO technique

Analysis & Classification of Acute Lymphoblastic Leukemia using KNN Algorithm

The early Detection of leukemia in cancer patients can greatly increase the chances of recovery. The leukemia can be identified by specific tests such as Cytogenetics and Immunophenotyping and morphological cell classification made by hematologist observing blood & marrow microscope images. This Diagnostic methods are costly and time consuming. We propose the use of morphological analysis of microscopic images of leukemic blood cells for the identification purpose, the morphological analysis just requires an image not a blood sample and hence is suitable for low cost and remote diagnostic system . The proposed system firstly individuates in the blood image the leucocytes from the others blood cells, then it select the lymphocyte cells (the ones interested by acute leukemia), it evaluates morphological indexes from those cells and finally it classifies the presence of the leukemia. The segmentation process provides two enhanced images for each blood cell; containing the cytoplasm and the nuclei regions. Unique features for each form of leukemia can then be extracted from the two images and used for identification

Classification of Acute Lymphocytic Leukemic Blood Cell Images using Hybrid CNN-Enhanced Ensemble SVM Models and Machine Learning Classifiers

Acute Lymphocytic Leukemia is a dangerous kind of malignant cancer caused due to the overproduction of white blood cells. The white blood cells in our body are responsible for fighting against infections, if the WBC increases the immunity will decrease and it would lead to serious health conditions. Malignant cancers such as ALL is life threatening if the disease is not diagnosed at an early stage. If a person is suffering from ALL the disease needs to be diagnosed at an early stage before it starts spreading, if it starts spreading the person’s chances of survival would also reduce. Here comes the need of an accurate automated system which would assist the oncologists to diagnose the disease as early as possible. In this paper some of the algorithms that are enhanced to detect and classify ALL are incorporated. In order to classify the Acute Lymphocytic Leukemia a hybrid model has been deployed to improve the accuracy of the diagnosis and it is termed as Hybrid CNN Enhanced Ensemble SVM for the classification of malignancy. Machine Learning classifiers are also used to design the system and it is then compared with enhanced CNN based on the performance metrics